Skip to main content
Paul Meyers, MD, Pediatric Hematology & Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

PaulAMeyersMD

Pediatric Hematology & Oncology New York, NY

Professor of Pediatrics, Cornell University-Weill Medical College

Overview of Dr. Meyers

Dr. Paul Meyers is a pediatric hematologist/oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 44 years. He is one of 92 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pediatric Hematology & Oncology. He also speaks multiple languages, including Spanish and French. He has more than 100 publications and over 500 citings.

Education & Training

  • Memorial Hospital
    Memorial Hospital1978 - 1979
  • Sloan-Kettering Institute
    Sloan-Kettering Institute1977 - 1979
  • Cornell Medical Center
    Cornell Medical Center1976 - 1976
  • Mt Sinai Hospital
    Mt Sinai Hospital1974 - 1976
  • Mt Sinai Hospital
    Mt Sinai Hospital1973 - 1974
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1973
  • Brown University
    Brown UniversityAB, Cum laude, 1966 - 1971

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NY State Medical License
    NY State Medical License 1974 - 2026
  • NJ State Medical License
    NJ State Medical License 1982 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors Castle Connolly, 2002-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prognostic factors for patients with sarcomas of the pelvic bones.  
    Kawai A, Healey JH, Boland P, Lin PP, Huvos AG, Meyers PA, Cancer 1998; 82:851-9
  • EWS-FLI1 Fusion transcript structure is an independent determinant of prognosis in Ewing’s sarcoma.  
    de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, Gerald WE, Jhanwar SC, Agrani P, Antonexcu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder ..., J Clin Onc 1998, 16:1248-1255
  • Intensification of preoperative chemotherapy for osteogenic sarcoma: The results of the Memorial Sloan-Kettering (T12) protocol.  
    Meyers PA, Gorlick R, Heller G, Casper E, Lane J, Huvos AG Healey JH, J Clin Onc 1998, 16:2452-2458
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • The addition of cycles of irinotecan/temozolomide (i/T) to cycles of vincristine, doxorubicin, cyclophosphamide (VDC) and cycles of ifosfamide, etoposide (IE) for the ... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Other

Press Mentions

  • Oncternal Therapeutics Announces Presentation of Interim Clinical Data on TK216, Its First-in-Class, Targeted ETS Inhibitor, in Patients with Relapsed or Refractory Ewing Sarcoma at the CTOS 2019 Annual Meeting
    Oncternal Therapeutics Announces Presentation of Interim Clinical Data on TK216, Its First-in-Class, Targeted ETS Inhibitor, in Patients with Relapsed or Refractory Ewing Sarcoma at the CTOS 2019 Annual MeetingNovember 14th, 2019
  • Oncternal Therapeutics Announces Presentation of Case Study of TK216 in Ewing Sarcoma Given at the Children’s Oncology Group Meeting
    Oncternal Therapeutics Announces Presentation of Case Study of TK216 in Ewing Sarcoma Given at the Children’s Oncology Group MeetingNovember 5th, 2019
  • Salarius Pharmaceuticals Adds Memorial Sloan Kettering Cancer Center and Nationwide Children’s Hospital as Clinical Sites for Phase 1/2 Trial of Seclidemstat in Ewing Sarcoma
    Salarius Pharmaceuticals Adds Memorial Sloan Kettering Cancer Center and Nationwide Children’s Hospital as Clinical Sites for Phase 1/2 Trial of Seclidemstat in Ewing SarcomaOctober 8th, 2019

Grant Support

  • Core BNational Cancer Institute2005–2009

Professional Memberships

Other Languages

  • Spanish, French

Hospital Affiliations